Filtration markers as predictors of ESRD and mortality: Individual participant data meta-analysis

Clinical Journal of the American Society of Nephrology

Volumn 12, Issue 1, 2017, Pages 69-78

  Inker, Lesley A ^a   Coresh, Josef ^b   Sang, Yingying ^b   Hsu, Chi Yuan ^c   Foster, Meredith C ^a   Eckfeldt, John H ^d   Karger, Amy B ^d   Nelson, Robert G ^e   Liu, Xun ^a   Sarnak, Mark ^a   Appel, Lawrence J ^b   Grams, Morgan ^b   Xie, Dawei ^f   Kimmel, Paul L ^e   Feldman, Harold ^f   Ramachandran, Vasan ^g   Levey, Andrew S ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Albuminuria; Beta 2 microglobulin; Chronic kidney disease; Follow up studies; Glomerular filtration rate; Humans; Intramolecular oxidoreductases; Kidney failure, chronic; Lipocalins; Prostaglandin R2 D isomerase; Renal insufficiency, chronic; Risk factors

Indexed keywords

BETA 2 MICROGLOBULIN; BETA TRACE PROTEIN; CREATININE; CYSTATIN C; PLASMA PROTEIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; ISOMERASE; LIPOCALIN; PROSTAGLANDIN R2 D-ISOMERASE;

ADULT; ALBUMINURIA; ARTICLE; DIABETES MELLITUS; DIALYSIS; DISEASE ASSOCIATION; END STAGE RENAL DISEASE; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBIDITY; MORTALITY; POPULATION RESEARCH; POPULATION RISK; SMOKING; AGED; BLOOD; CHRONIC KIDNEY FAILURE; GLOMERULUS FILTRATION RATE; META ANALYSIS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RISK ASSESSMENT; RISK FACTOR; URINE;

ADULT; AGED; ALBUMINURIA; BETA 2-MICROGLOBULIN; BIOMARKERS; CREATININE; CYSTATIN C; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; KIDNEY FAILURE, CHRONIC; LIPOCALINS; MALE; MIDDLE AGED; MORTALITY; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS;

EID: 85021636091     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03660316     Document Type: Article

References (23)

1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 298: 2038–2047, 2007
2. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT; Chronic Kidney Disease Prognosis Consortium: Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis. Lancet 375: 2073–2081, 2010
3. Astor BC, Matsushita K, Gansevoort RT, van der Velde M, Woodward M, Levey AS, Jong PE, Coresh J, Astor BC, Matsushita K, Gansevoort RT, van der Velde M, Woodward M, Levey AS, de Jong PE, Coresh J, El-Nahas M, Eckardt KU, Kasiske BL, Wright J, Appel L, Greene T, Levin A, Djurdjev O, Wheeler DC, Landray MJ, Townend JN, Emberson J, Clark LE, Macleod A, Marks A, Ali T, Fluck N, Prescott G, Smith DH, Weinstein JR, Johnson ES, Thorp ML, Wetzels JF, Blankestijn PJ, van Zuilen AD, Menon V, Sarnak M, Beck G, Kronenberg F, Kollerits B, Froissart M, Stengel B, Metzger M, Remuzzi G, Ruggenenti P, Perna A, Heerspink HJ, Brenner B, de Zeeuw D, Rossing P, Parving HH, Auguste P, Veldhuis K, Wang Y, Camarata L, Thomas B, Manley T; Chronic Kidney Disease Prognosis Consortium: Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int 79: 1331–1340, 2011
4. Gansevoort RT, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J; Chronic Kidney Disease Prognosis Consortium: Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int 80: 93–104, 2011
5. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS; CKD-EPI Investigators: Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367: 20– 29, 2012
6. Shlipak MG, Matsushita K, Ärnlöv J, Inker LA, Katz R, Polkinghorne KR, Rothenbacher D, Sarnak MJ, Astor BC, Coresh J, Levey AS, Gansevoort RT; CKD Prognosis Consortium: Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med 369: 932–943, 2013
7. Eckfeldt JH, Karger AB, Miller WG, Rynders GP, Inker LA: Performance in measurement of serum cystatin C by laboratories participating in the college of American Pathologists 2014 CYS Survey. Arch Pathol Lab Med 139: 888–893, 2015
8. Foster MC, Inker LA, Hsu CY, Eckfeldt JH, Levey AS, Pavkov ME, Myers BD, Bennett PH, Kimmel PL, Vasan RS, Coresh J, Nelson RG; CKD Biomarkers Consortium: Filtration markers as predictors of ESRD and mortality in Southwestern American Indians with type 2 diabetes. Am J Kidney Dis 66: 75–83, 2015
9. Foster MC, Inker LA, Levey AS, Selvin E, Eckfeldt J, Juraschek SP, Coresh J; CKD Biomarkers Consortium: Novel filtration markers as predictors of all-cause and cardiovascular mortality in US adults. Am J Kidney Dis 62: 42–51, 2013
10. Astor BC, Shafi T, Hoogeveen RC, Matsushita K, Ballantyne CM, Inker LA, Coresh J: Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population. Am J Kidney Dis 59: 653–662, 2012
11. Tangri N, Inker LA, Tighiouart H, Sorensen E, Menon V, Beck G, Shlipak M, Coresh J, Levey AS, Sarnak MJ: Filtration markers may have prognostic value independent of glomerular filtration rate. J Am Soc Nephrol 23: 351–359, 2012
12. Bhavsar NA, Appel LJ, Kusek JW, Contreras G, Bakris G, Coresh J, Astor BC; AASK Study Group: Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD. Am J Kidney Dis 58: 886–893, 2011
13. Foster MC, Coresh J, Hsu CY, Xie D, Levey AS, Nelson RG, Eckfeldt JH, Vasan RS, Kimmel PL, Schelling J, Simonson M, Sondheimer JH, Anderson AH, Akkina S, Feldman HI, Kusek JW, Ojo AO, Inker LA: Serum beta-trace protein and beta2-microglobulin as predictors of ESRD, mortality, and cardiovascular disease in adults with CKD in the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis 68: 68–76, 2016
14. Inker LA, Tighiouart H, Coresh J, Foster MC, Anderson AH, Beck GJ, Contreras G, Green T, Karger A, Kusek JW, Lash J, Lewis J, Schelling JR, Navaneethan SD, Sondheimer J, Shafi T, Levey AS: GFR estimation using beta-trace protein and beta-2-microglobulin in CKD. Am J Kidney Dis 67: 40–48, 2016
15. Zellner A: An efficient method of estimating seemingly unrelated regressions and tests for aggregation bias. J Am Stat Assoc 57: 348–368, 1962
16. Pencina MJ, D’Agostino Sr RB, D’Agostino Jr RB, Vasan RS: Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27: 157–172; discussion 207–112, 2008
17. Stevens LA, Schmid CH, Greene T, Li L, Beck GJ, Joffe MM, Froissart M, Kusek JW, Zhang YL, Coresh J, Levey AS: Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 75: 652–660, 2009
18. Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan GC, de Jong PE: Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 65: 1416–1421, 2004
19. Rule AD, Bailey KR, Lieske JC, Peyser PA, Turner ST: Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated with chronic kidney disease. Kidney Int 83: 1169–1176, 2013
20. Liu X, Foster MC, Tighiouart H, Anderson AH, Beck GJ, Contreras G, Coresh J, Eckfeldt JH, Feldman H, Greene T, Hamm LL, He J, Hortwitz E, Lewis J, Ricardo AC, Shou H, Townsend RR, Weir MR, Inker LA, Levey AS; CRIC (Chronic Renal Insufficiency Cohort) Study Investigators: Non-GFR determinants of low-molecular-weight serum protein filtration markers in chronic kidney disease [published online ahead of print September 20, 2016]. Am J Kidney Dis doi: 10.1053/j.ajkd.2016.07.021
21. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group: KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3: 1–150, 2013
22. Tangri N, Grams ME, Levey AS, Coresh J, Appel LJ, Astor BC, Chodick G, Collins AJ, Djurdjev O, Elley CR, Evans M, Garg AX, Hallan SI, Inker LA, Ito S, Jee SH, Kovesdy CP, Kronenberg F, Heerspink HJ, Marks A, Nadkarni GN, Navaneethan SD, Nelson RG, Titze S, Sarnak MJ, Stengel B, Woodward M, Iseki K: Multinational assessment of accuracy of equations for predicting risk of kidney failure: A meta-analysis. Jama 315: 164–174, 2016
23. Thurlow JS, Abbott KC, Linberg A, Little D, Fenderson J, Olson SW: SCr and SCysC concentrations before and after traumatic amputation in male soldiers: A case-control study. Am J Kidney Dis 63: 167–170, 2014